华法林衍生物作为自由基清除剂:基于库马林支架的线性回归模型与体外验证
E Goya-Jorge1,2, M Pedraza-Beltrán1, R T Pareja-Rodríguez1
1Department of Pharmacy, Faculty of Chemistry and Pharmacy, Universidad Central "Marta Abreu" de las Villas, Santa Clara, Cuba.
研究人员使用分子描述器开发了抗氧化剂活性的预测模型. 该模型成功地确定了具有显著自由基清除潜力的新型华法林衍生物,展示了这些化合物的新应用.
科学领域:
- 药用化学 医学化学
- 计算化学的计算化学
- 药理学 药理学 是一个学科.
背景情况:
- 反应性氧物种 (ROS) 导致与氧化压力相关的疾病.
- 抗氧化剂对于减轻ROS至关重要.
- 库马林衍生物由于其潜在的抗氧化特性而引起人们的兴趣.
研究的目的:
- 开发一种定量结构-活性关系 (QSAR) 模型,用于预测抗氧化剂活性.
- 为了探索华法林衍生物的抗氧化潜力.
- 用实验数据验证QSAR模型.
主要方法:
- 使用七个分子描述符开发了一个多重线性回归 (MLR) QSAR模型.
- 预测了基于库马林的化合物的自由基清除活性 (DPPH测定IC50).
- 合成并测试了七种新的华法林衍生物的抗氧化活性.
- 用外部实验数据验证了MLR-QSAR模型.
主要成果:
- 该MLR-QSAR模型显示了高的预测准确性 (r2=81.04,Q2ext=75.38).
- 华法林衍生物的预测抗氧化活性与实验结果 (r=0.63) 有很好的相关性.
- 所有测试的华法林衍生物都表现出显著的自由基清除活性.
结论:
- 可解释的MLR-QSAR模型可以可靠地预测抗氧化剂活性.
- 华法林衍生物具有显著的,以前未被探索的抗氧化潜力.
- 这种in silico-in vitro方法有效指导发现新的基于库马林的抗氧化剂.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
09:56Real-time Monitoring of Reactions Performed Using Continuous-flow Processing: The Preparation of 3-Acetylcoumarin as an Example
Published on: November 18, 2015
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Therapeutic Drug Monitoring: Drug Analysis Methods
